Order affirmed, with $50 costs and disbursements.
The respondent, International Hormones, Inc., manufactured hormone suspensions which were sold to Bel-Mar Laboratories, Inc. (Bel-Mar), which then transferred the suspensions to vials, into which other materials were allegedly inserted. The resulting product was then resold to medical facilities for use in injections. The Federal Food and Drug Administration (F. D. A.) ordered a recall of Bel-Mar's products because...
Let's get started
Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.